ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Overweight
Diabetic Foot
Foot Ulcer

Diabetes trials near Berlin, BE, DEU:

Combined Active Treatment in Type 2 Diabetes with NASH (COMBAT_T2_NASH)

type 2 diabetes....

Active, not recruiting
Type 2 Diabetes
Non-alcoholic Steatohepatitis (NASH)
Drug: Empagliflozin 10mg oral tablet / Semaglutide 1mg pen injector
Drug: Placebo matching empagliflozin and placebo pen injector matching semaglutide

Phase 4

German Diabetes Center

Berlin, Germany and 25 other locations

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd also known as retogatein compared...

Active, not recruiting
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Berlin, Germany and 59 other locations

To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safe...

Active, not recruiting
Diabetes
Coronary Artery Disease
Device: XIENCE Everolimus Eluting Coronary Stent System (XIENCE family)
Device: Abluminus DES+ Sirolimus Eluting Stent System (SES)
Concept Medical
Concept Medical

Berlin, Germany and 89 other locations

study medicine to help adults with obesity or overweight and type 2 diabetes lose weight. Being overweight or obese means carrying too much ...

Enrolling
Diabetes, Type 2
Type 2 Diabetes
Drug: PF-08653944
Other: Placebo

Phase 3

Pfizer
Pfizer

Berlin, Germany and 182 other locations

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting
Diabetic Cardiomyopathies
Drug: AT-001
Drug: Placebo

Phase 3

Applied Therapeutics

Berlin, Germany and 78 other locations

The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.

Active, not recruiting
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Drug: Maridebart cafraglutide
Drug: Placebo

Phase 3

Amgen
Amgen

Berlin, Germany and 187 other locations

New

The study is testing UBT251 in participants with type 2 diabetes. The purpose of this clinical study is to find out if UBT251 is effective a...

Not yet enrolling
Diabetes Mellitus, Type 2
Drug: UBT251
Drug: Semaglutide Placebo

Phase 2

Novo Nordisk
Novo Nordisk

Berlin, Germany and 68 other locations

the efficacy and safety of eloralintide compared with placebo for body weight reduction in participants with overweight or obesity and type 2 diabetes...

Enrolling
Overweight
Obesity
Drug: Eloralintide
Drug: Placebo

Phase 3

Lilly
Lilly

Berlin, Germany and 158 other locations

The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with oral semaglutide in adults with T2DM an...

Begins enrollment this month
Type 2 Diabetes Mellitus
Drug: Elecoglipron
Drug: Semaglutide

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 157 other locations

The primary purpose of this study is to evaluate the safety and efficacy of medical cannabis aerosol containing 0.25, 0.50, 1.0 milligrams (mg) delta...

Active, not recruiting
Diabetic Peripheral Neuropathic Pain
Drug: Medical Cannabis
Drug: Placebo

Phase 2

Syqe Medical

Berlin, State of Berlin, Germany and 37 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems